Abstract
Commentary to:
Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrations
Shi-Yong Sun, Claudia P Schroeder, Ping Yue, Dafna Lotan, Waun K Hong, Reuben Lotan
Cancer Biol Ther 4(4); 2005:407-413